Generics News

Generics News

Mylan Launches Generic Zosyn

Mylan announced the launch of Piperacillin and Tazobactam for Injection, the generic version of Pfizer's Zosyn injection.

Amneal Launches Generic Abilify Oral Solution

Amneal announced the launch of Aripiprazole Oral Solution, the generic version of Otsuka's Abilify Oral Solution.

Lannett Approved for Generic Abilify Oral Solution

Lannett announced that its subsidiary Silarx has received approval from the Food and Drug Administration (FDA) for Aripiprazole Oral Solution, the generic version of Otsuka's Abilify Oral Solution.

Dr. Reddy's Launches Generic Mirapex ER

Dr. Reddy's Laboratories announced the launch of Pramipexole Dihydrochloride Extended-Release Tablets, the generic version of Boehringer Ingelheim's Mirapex ER.

Fresenius Kabi Launches Generic Nimbex

Fresenius Kabi announced the launch of Cisatracurium Besylate Injection, the generic equivalent of AbbVie's Nimbex.

Mylan Launches Generic Lidoderm Patch

Mylan announced the launch of Lidocaine Patch 5%, the generic version of Endo's Lidoderm.

Upsher-Smith Approved for Generic Namenda

Upsher-Smith announced that the Food and Drug Administration (FDA) has approved its abbreviated new drug application (ANDA) for Memantine HCl Tablets, the generic version of Actavis' Namenda.

Mylan Launches Generic Nexium

Mylan announced the launch of Esomeprazole Magnesium Delayed-Release Capsules, the generic version of AstraZeneca's Nexium.

Par Approved for Generic Sodium Edecrin

Par Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved Ethacrynate Sodium for Injection, the first generic version of Aton Pharma's Sodium Edecrin.

Par Launches Generic Megace ES

Par Pharmaceuticals announced the launch of Megestrol Acetate Suspension, the generic version of its brand Megace ES.